. 2019 Mar 19;28(3):267–277. doi: 10.1097/MNH.0000000000000491

Table 3.

Mean eGFR (ml/min/1.73 m²) change from baseline over 24-month treatment period comparing sodium citrate and no sodium citrate groups

	Sodium citrate group (N = 30)	No sodium citrate (N = 29)	P value
Baseline^a	33.02 (8.48) 18–57.6	33.38 (8.39) 19–49	0.8706
Month 6^a	32.67 (8.21) 18–56	32.52 (8.33) 18–47	0.9449
Month 30^a	29.47 (8.77) 14–52	24.93 (9.74) 10–44	0.0656
Change (month 30–month 6)^a	−3.2 (1.45) −6 to 0	−7.59 (3.26) −17 to −2	<0.0001
% Change (month 30–month 6)^a	−10.82% (6.44%) −24 to 0%	−25.72% (13.84%) −53.13 to −4.35%	<0.0001
≥40% decrease eGFR^b (month 6 to month 30)	0	8 (27.59%)

eGFR, estimated glomerular filtration rate.

^aValues are mean (SD); minimum to maximum.

^bValues are number (percentage).

Adapted with permission from [17].